FilingReader Intelligence
Marksans Pharma gets UK authorization for diabetes drugs
August 18, 2025 at 06:59 AM UTC•By FilingReader AI
Marksans Pharma announced its UK subsidiary Relonchem Limited received marketing authorization from UK MHRA for three Metformin Hydrochloride prolonged release tablets (500mg, 750mg, and 1000mg).
The approval expands the company's product portfolio for global markets.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:MARKSANS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Marksans Pharma publishes news
Free account required • Unsubscribe anytime